CIK 0001819133 · Non-accelerated filer<br>Smaller reporting company
Tango Therapeutics, Inc.
Sign in to watch- Ticker
- TNGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (857) 320-4900
- Business address
- 201 BROOKLINE AVENUE, SUITE 901, BOSTON, MA, 02215
- Former names
- BCTG Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,858,086
- in 6 filings, $1.9M under 10b5-1 plans
Net −$1,858,086. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 18 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-29 | Ketchum John B Director | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2023-08-11 | Boxer Capital, LLC Director | Grant or award | +475,000 | $5.15 | $2.4M | 743,542 |
| 2023-08-11 | Boxer Capital, LLC Director | Grant or award · Prefunded Warrant | +2,340,579 | $5.15 | $12.1M | 2,340,579 |
| 2023-08-11 | Boxer Capital, LLC See remarks | Purchase | +475,000 | $5.15 | $2.4M | 743,542 |
| 2023-08-11 | Boxer Capital, LLC See remarks | Purchase · Prefunded Warrant | +2,340,579 | $5.15 | $12.1M | 2,340,597 |
| 2023-06-06 | Rothenberg Mace Director | Grant or award | +5,000 | 5,000 | ||
| 2023-06-06 | Rothenberg Mace Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2023-06-06 | Calhoun Lesley Ann Director | Grant or award | +5,000 | 5,000 | ||
| 2023-06-06 | Calhoun Lesley Ann Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2023-06-06 | Borisy Alexis Director | Grant or award | +5,000 | 5,000 | ||
| 2023-06-06 | Borisy Alexis Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2023-06-06 | Huber Reid M Director | Grant or award | +5,000 | 5,000 | ||
| 2023-06-06 | Huber Reid M Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2023-06-06 | Peters Malte Director | Grant or award | +5,000 | 5,000 | ||
| 2023-06-06 | Peters Malte Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2023-06-06 | Davis Aaron I. Director | Grant or award | +5,000 | 5,000 | ||
| 2023-06-06 | Davis Aaron I. Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2023-03-01 | Crystal Adam See Remarks | Grant or award | +81,250 | 81,250 | ||
| 2023-03-01 | Crystal Adam See Remarks | Grant or award · Stock Option (Right to Buy) | +487,500 | 487,500 | ||
| 2023-03-01 | Weber Barbara Chief Executive Officer | Grant or award | +89,545 | 1,457,137 |
Page 10 of 11 · 211 trades